NCT02129010View on ClinicalTrials.gov

The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Subarachnoid HemorrhageTerson SyndromeCSF-proteines
Trial Locations (1)

9007

Cantonal Hospital St. Gallen, Sankt Gallen

All Listed Sponsors
collaborator

Innogenetics N.V., Belgium

UNKNOWN

lead

Holger Joswig

OTHER

NCT02129010 - The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage | Biotech Hunter | Biotech Hunter